<DOC>
	<DOCNO>NCT00874601</DOCNO>
	<brief_summary>The manipulation blood pressure acute cerebral ischemia matter debate . The investigator clearly need detailed data antihypertensive treatment affect outcome acute phase stroke . This study assess effect modest blood pressure ( BP ) lower manipulation acute period ischemic stroke death dependency 90-day .</brief_summary>
	<brief_title>Valsartan Efficacy Modest Blood Pressure Reduction Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Age 18 year Patients admit within 24 hour enrol within 48 hour qualify ischemic stroke onset Patients systolic blood pressure 150 mm Hg 185 mm Hg least twice 3 time 5 minute interval rest Baseline NIHSS score least 2 point , 21 point Full functional independence prior present stroke indicate estimate premorbid mRS score 0 1 Informed consent patient authorized representative must obtain write enrollment study Patients receive thrombolytic therapy ( intravenous intraarterial ) Patients acute Intracerebral hemorrhage diagnose neuroimaging Patients moderate severe cardiac failure ( New York Heart Association class III IV ) Patients medical condition need urgent special antihypertentive therapy , hypertensive encephalopathy , aortic dissection , acute renal failure , acute pulmonary edema , acute myocardial infarction Comatose screen Known suspect cerebral aneurysm arteriovenous malformation Any clinical relevant serious disease , include uncontrolled Diabetes , severe liver disease , severe renal disease time randomization Life expectancy le 3 month due comorbid condition , malignancy Participation another drug trial plan use vascular intervention within previous 30 day Women pregnant , breast feeding , child bearing potential Contraindication ARBs , history angioedema ARBs , renovascular hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>acute ischemic stroke</keyword>
	<keyword>blood pressure</keyword>
	<keyword>valsartan</keyword>
	<keyword>death</keyword>
	<keyword>dependancy</keyword>
</DOC>